ArticleiScience2026

Tuberostemonine ameliorates Alzheimer's disease pathology by suppression of the p38 MAPK signaling pathway.

Yingzhou Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.